Comparing Greenwich LifeSciences (NASDAQ:GLSI) and Immune Therapeutics (OTCMKTS:IMUN)
Greenwich LifeSciences (NASDAQ:GLSI – Get Free Report) and Immune Therapeutics (OTCMKTS:IMUN – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, analyst recommendations, valuation and institutional ownership. Institutional and Insider Ownership 4.9% of Greenwich […]
More Stories
First Trust Global Tactical Commodity Strategy Fund (NASDAQ:FTGC) Reaches New 1-Year High – Here’s Why
First Trust Global Tactical Commodity Strategy Fund (NASDAQ:FTGC – Get Free Report)’s stock price reached a new 52-week high on...
Banco de Sabadell, S.A. (OTCMKTS:BNDSY) Short Interest Up 1,000.0% in December
Banco de Sabadell, S.A. (OTCMKTS:BNDSY – Get Free Report) was the recipient of a significant growth in short interest in...
Tapestry (NYSE:TPR) Hits New 1-Year High – Here’s Why
Tapestry, Inc. (NYSE:TPR – Get Free Report) hit a new 52-week high on Wednesday . The stock traded as high...
Campbell Newman Asset Management Inc. Sells 6,426 Shares of Honeywell International Inc. (NASDAQ:HON)
Campbell Newman Asset Management Inc. lowered its holdings in shares of Honeywell International Inc. (NASDAQ:HON – Free Report) by 7.1%...
Canadian Tire (TSE:CTC.A) Hits New 1-Year High – What’s Next?
Canadian Tire Co. Limited (TSE:CTC.A – Get Free Report) hit a new 52-week high during trading on Wednesday . The...
Cisco Systems (NASDAQ:CSCO) Sets New 12-Month High – Still a Buy?
Cisco Systems, Inc. (NASDAQ:CSCO – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Wednesday...